Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENND10 pseudogene 1 (DENND10P1) is classified as a pseudogene[2][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are generally nonfunctional due to mutations or lack of regulatory elements[6]. DENND10P1 is predicted to retain sequence similarity to the functional DENND10 gene, which encodes a guanyl-nucleotide exchange factor (GEF) known to regulate endosomal transport and Rab GTPase signaling[1][3][4]. However, DENND10P1 itself is not believed to encode an active protein and is not considered a druggable target, receptor, enzyme, transporter, or otherwise viable therapeutic target[2][5]. Its main biological significance may relate to general pseudogene regulatory effects, such as competing for miRNA binding sites or gene conversion mechanisms, though such functions are not documented for DENND10P1 specifically[6]. There is no evidence for DENND10P1 involvement in disease, drug interactions, or use as a biomarker or safety concern.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENND10 pseudogene 1 (DENND10P1).